Steven Stein
Chief Tech/Sci/R&D Officer en INCYTE CORPORATION .
Fortuna: 6 M $ al 31/03/2024
Perfil
Steven H. Stein ocupa el cargo de Director Médico y Vicepresidente Ejecutivo de Incyte Corp. El Dr. Stein también forma parte del consejo de administración de Kura Oncology, Inc. En su anterior carrera, el Dr. Stein fue Vicepresidente de Oncología Global en GlaxoSmithKline (Nueva Jersey), Vicepresidente Senior de Desarrollo Clínico y Asuntos Médicos en Novartis Oncology, Inc. y Vicepresidente Senior de Desarrollo Clínico y Asuntos Médicos en Novartis Pharmaceuticals Corp. El Dr. Stein se doctoró en la Universidad de Witwatersrand.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INCYTE CORPORATION
0.04% | 14/02/2024 | 97 595 ( 0.04% ) | 6 M $ | 31/03/2024 |
KURA ONCOLOGY, INC.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Steven Stein
| Empresas | Cargo | Inicio |
|---|---|---|
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 02/03/2015 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Steven Stein.
| Empresas | Cargo | Fin |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Director/Board Member | 14/02/2024 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/02/2015 |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | 01/04/2011 |
| KURA ONCOLOGY, INC. | Director/Board Member | - |
Formación de Steven Stein.
| University of the Witwatersrand | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Steven Stein
